Kayyem Jon Faiz 13D and 13G filings for Inhibrx Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 5:09 pm Sale | 2023-12-31 | 13G | Inhibrx Biosciences, Inc. INBX | Kayyem Jon Faiz | 3,308,123 7.000% | -97,686 (-2.87%) | Filing |
| 2021-02-12 4:14 pm Purchase | 2020-12-31 | 13G | Inhibrx Biosciences, Inc. INBX | Kayyem Jon Faiz | 3,405,809 9.000% | 3,405,809 (New Position) | Filing |